Intas Pharma launches first etanercept biosimilar
Intas Pharmaceuticals has launched INTACEPT, the first biosimilar to Amgen’s Enbrel (etanercept). INTACEPT has been launched in two strengths, 25mg in 0.5... Read More
Cadila acquiring JV partner’s 50% stake in Zydus BSV Pharma
Posted on27 Mar 2015
Comments0
Cadila Healthcare on Thursday acquired 50 percent stake from Bharat Serums and Vaccines in its JV firm, Zydus BSV Pharma, to... Read More
Cipla to launch generic Sovaldi in India
Cipla is launching low-cost version of Gilead Sciences’ Sovaldi in India. With a launch planned this week, Cipla will become the latest... Read More
FDA Launches Drug Shortages Mobile App
U.S. Food and Drug Administration launched the agency’s first mobile application (app) specifically designed to speed public access to valuable information about drug... Read More
After Zydus Candila & Natco, Now DRL launching Gilead’s Sofosbuvir in India
Posted on24 Mar 2015
Comments0
Dr Reddy’s Laboratories entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences’ Hepatitis C drug... Read More
A Case of MSD – Glenmark Sitagliptin Patent Battle
Posted on24 Mar 2015
TagsGlemark Zita, Glenmark Zitamet, Januvia, MSD - Glenmark Sitagliptin Patent Battle, Sitagliptin, Sitagliptin patent, Zita
Comments0
The US firm said that it had invented ‘Sitagliptin’ salt that is used in its anti-diabetes drugs and holds the patent for... Read More
ZydusCadila to launch Gilead’s Sovaldi in India
Posted on20 Mar 2015
TagsSofosbuvir, Sovaldi, Zydus biosimilar, Zydus Gliead deal, Zydus Heptiza, ZydusCadila to launch Gilead's Sovaldi in India
Comments0
The two companies have entered into a generic, non-exclusive licensing agreement to manufacture Sofobuvir and an investigational single tablet regime of Ledipasvir/... Read More
FDA approval of 1st biosimilar cancer drug
Posted on11 Mar 2015
Comments0
On Friday, FDA approved Zarxio, Novartis AG’s version of Amgen’s biologic drug Neupogen, making it the first biosimilar medication approved by USFDA.... Read More
Natco launched first generic version of Sofosbuvir in Nepal
Posted on11 Mar 2015
Comments0
Natco Pharma has launched the first generic version of Sofosbuvir in Nepal. Sofosbuvir is a medicine used for chronic hepatitis C infection... Read More
Sun Pharma buys GSK’s opiates business in Australia
Posted on04 Mar 2015
Comments0
Sun Pharmaceutical Industries has acquired multinational drug maker GlaxoSmithKline’s opiates business in Australia. GSK’s out-going product portfolio consists of poppy-derived opiate raw... Read More